Medical Care

Global ICU-acquired Acute Kidney Treatment Market Research Report 2024

The global ICU-acquired Acute Kidney Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for ICU-acquired Acute Kidney Treatment, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding ICU-acquired Acute Kidney Treatment.
Report Scope
The ICU-acquired Acute Kidney Treatment market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global ICU-acquired Acute Kidney Treatment market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the ICU-acquired Acute Kidney Treatment companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Quark Pharmaceuticals
Fresenius Medical Care
B. Braun
Baxter international
Angion Biomedica Corp
Asahi Kasei Medical
Segment by Type
Pre-renal
Intrinsic-renal
Post-renal
Segment by Application
Public Hospital
Private Hospital
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of ICU-acquired Acute Kidney Treatment companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Pre-renal
1.2.3 Intrinsic-renal
1.2.4 Post-renal
1.3 Market by Application
1.3.1 Global ICU-acquired Acute Kidney Treatment Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Public Hospital
1.3.3 Private Hospital
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global ICU-acquired Acute Kidney Treatment Market Perspective (2019-2030)
2.2 ICU-acquired Acute Kidney Treatment Growth Trends by Region
2.2.1 Global ICU-acquired Acute Kidney Treatment Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 ICU-acquired Acute Kidney Treatment Historic Market Size by Region (2019-2024)
2.2.3 ICU-acquired Acute Kidney Treatment Forecasted Market Size by Region (2025-2030)
2.3 ICU-acquired Acute Kidney Treatment Market Dynamics
2.3.1 ICU-acquired Acute Kidney Treatment Industry Trends
2.3.2 ICU-acquired Acute Kidney Treatment Market Drivers
2.3.3 ICU-acquired Acute Kidney Treatment Market Challenges
2.3.4 ICU-acquired Acute Kidney Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top ICU-acquired Acute Kidney Treatment Players by Revenue
3.1.1 Global Top ICU-acquired Acute Kidney Treatment Players by Revenue (2019-2024)
3.1.2 Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Players (2019-2024)
3.2 Global ICU-acquired Acute Kidney Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by ICU-acquired Acute Kidney Treatment Revenue
3.4 Global ICU-acquired Acute Kidney Treatment Market Concentration Ratio
3.4.1 Global ICU-acquired Acute Kidney Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by ICU-acquired Acute Kidney Treatment Revenue in 2023
3.5 ICU-acquired Acute Kidney Treatment Key Players Head office and Area Served
3.6 Key Players ICU-acquired Acute Kidney Treatment Product Solution and Service
3.7 Date of Enter into ICU-acquired Acute Kidney Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 ICU-acquired Acute Kidney Treatment Breakdown Data by Type
4.1 Global ICU-acquired Acute Kidney Treatment Historic Market Size by Type (2019-2024)
4.2 Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Type (2025-2030)
5 ICU-acquired Acute Kidney Treatment Breakdown Data by Application
5.1 Global ICU-acquired Acute Kidney Treatment Historic Market Size by Application (2019-2024)
5.2 Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America ICU-acquired Acute Kidney Treatment Market Size (2019-2030)
6.2 North America ICU-acquired Acute Kidney Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America ICU-acquired Acute Kidney Treatment Market Size by Country (2019-2024)
6.4 North America ICU-acquired Acute Kidney Treatment Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe ICU-acquired Acute Kidney Treatment Market Size (2019-2030)
7.2 Europe ICU-acquired Acute Kidney Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2019-2024)
7.4 Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size (2019-2030)
8.2 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2019-2024)
8.4 Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America ICU-acquired Acute Kidney Treatment Market Size (2019-2030)
9.2 Latin America ICU-acquired Acute Kidney Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2019-2024)
9.4 Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size (2019-2030)
10.2 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2019-2024)
10.4 Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Quark Pharmaceuticals
11.1.1 Quark Pharmaceuticals Company Detail
11.1.2 Quark Pharmaceuticals Business Overview
11.1.3 Quark Pharmaceuticals ICU-acquired Acute Kidney Treatment Introduction
11.1.4 Quark Pharmaceuticals Revenue in ICU-acquired Acute Kidney Treatment Business (2019-2024)
11.1.5 Quark Pharmaceuticals Recent Development
11.2 Fresenius Medical Care
11.2.1 Fresenius Medical Care Company Detail
11.2.2 Fresenius Medical Care Business Overview
11.2.3 Fresenius Medical Care ICU-acquired Acute Kidney Treatment Introduction
11.2.4 Fresenius Medical Care Revenue in ICU-acquired Acute Kidney Treatment Business (2019-2024)
11.2.5 Fresenius Medical Care Recent Development
11.3 B. Braun
11.3.1 B. Braun Company Detail
11.3.2 B. Braun Business Overview
11.3.3 B. Braun ICU-acquired Acute Kidney Treatment Introduction
11.3.4 B. Braun Revenue in ICU-acquired Acute Kidney Treatment Business (2019-2024)
11.3.5 B. Braun Recent Development
11.4 Baxter international
11.4.1 Baxter international Company Detail
11.4.2 Baxter international Business Overview
11.4.3 Baxter international ICU-acquired Acute Kidney Treatment Introduction
11.4.4 Baxter international Revenue in ICU-acquired Acute Kidney Treatment Business (2019-2024)
11.4.5 Baxter international Recent Development
11.5 Angion Biomedica Corp
11.5.1 Angion Biomedica Corp Company Detail
11.5.2 Angion Biomedica Corp Business Overview
11.5.3 Angion Biomedica Corp ICU-acquired Acute Kidney Treatment Introduction
11.5.4 Angion Biomedica Corp Revenue in ICU-acquired Acute Kidney Treatment Business (2019-2024)
11.5.5 Angion Biomedica Corp Recent Development
11.6 Asahi Kasei Medical
11.6.1 Asahi Kasei Medical Company Detail
11.6.2 Asahi Kasei Medical Business Overview
11.6.3 Asahi Kasei Medical ICU-acquired Acute Kidney Treatment Introduction
11.6.4 Asahi Kasei Medical Revenue in ICU-acquired Acute Kidney Treatment Business (2019-2024)
11.6.5 Asahi Kasei Medical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Pre-renal
Table 3. Key Players of Intrinsic-renal
Table 4. Key Players of Post-renal
Table 5. Global ICU-acquired Acute Kidney Treatment Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global ICU-acquired Acute Kidney Treatment Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global ICU-acquired Acute Kidney Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global ICU-acquired Acute Kidney Treatment Market Share by Region (2019-2024)
Table 9. Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global ICU-acquired Acute Kidney Treatment Market Share by Region (2025-2030)
Table 11. ICU-acquired Acute Kidney Treatment Market Trends
Table 12. ICU-acquired Acute Kidney Treatment Market Drivers
Table 13. ICU-acquired Acute Kidney Treatment Market Challenges
Table 14. ICU-acquired Acute Kidney Treatment Market Restraints
Table 15. Global ICU-acquired Acute Kidney Treatment Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global ICU-acquired Acute Kidney Treatment Market Share by Players (2019-2024)
Table 17. Global Top ICU-acquired Acute Kidney Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICU-acquired Acute Kidney Treatment as of 2023)
Table 18. Ranking of Global Top ICU-acquired Acute Kidney Treatment Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by ICU-acquired Acute Kidney Treatment Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players ICU-acquired Acute Kidney Treatment Product Solution and Service
Table 22. Date of Enter into ICU-acquired Acute Kidney Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global ICU-acquired Acute Kidney Treatment Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Type (2019-2024)
Table 26. Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Type (2025-2030)
Table 28. Global ICU-acquired Acute Kidney Treatment Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Application (2019-2024)
Table 30. Global ICU-acquired Acute Kidney Treatment Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global ICU-acquired Acute Kidney Treatment Revenue Market Share by Application (2025-2030)
Table 32. North America ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America ICU-acquired Acute Kidney Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America ICU-acquired Acute Kidney Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe ICU-acquired Acute Kidney Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America ICU-acquired Acute Kidney Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size by Country (2025-2030) & (US$ Million)
Table 47. Quark Pharmaceuticals Company Detail
Table 48. Quark Pharmaceuticals Business Overview
Table 49. Quark Pharmaceuticals ICU-acquired Acute Kidney Treatment Product
Table 50. Quark Pharmaceuticals Revenue in ICU-acquired Acute Kidney Treatment Business (2019-2024) & (US$ Million)
Table 51. Quark Pharmaceuticals Recent Development
Table 52. Fresenius Medical Care Company Detail
Table 53. Fresenius Medical Care Business Overview
Table 54. Fresenius Medical Care ICU-acquired Acute Kidney Treatment Product
Table 55. Fresenius Medical Care Revenue in ICU-acquired Acute Kidney Treatment Business (2019-2024) & (US$ Million)
Table 56. Fresenius Medical Care Recent Development
Table 57. B. Braun Company Detail
Table 58. B. Braun Business Overview
Table 59. B. Braun ICU-acquired Acute Kidney Treatment Product
Table 60. B. Braun Revenue in ICU-acquired Acute Kidney Treatment Business (2019-2024) & (US$ Million)
Table 61. B. Braun Recent Development
Table 62. Baxter international Company Detail
Table 63. Baxter international Business Overview
Table 64. Baxter international ICU-acquired Acute Kidney Treatment Product
Table 65. Baxter international Revenue in ICU-acquired Acute Kidney Treatment Business (2019-2024) & (US$ Million)
Table 66. Baxter international Recent Development
Table 67. Angion Biomedica Corp Company Detail
Table 68. Angion Biomedica Corp Business Overview
Table 69. Angion Biomedica Corp ICU-acquired Acute Kidney Treatment Product
Table 70. Angion Biomedica Corp Revenue in ICU-acquired Acute Kidney Treatment Business (2019-2024) & (US$ Million)
Table 71. Angion Biomedica Corp Recent Development
Table 72. Asahi Kasei Medical Company Detail
Table 73. Asahi Kasei Medical Business Overview
Table 74. Asahi Kasei Medical ICU-acquired Acute Kidney Treatment Product
Table 75. Asahi Kasei Medical Revenue in ICU-acquired Acute Kidney Treatment Business (2019-2024) & (US$ Million)
Table 76. Asahi Kasei Medical Recent Development
Table 77. Research Programs/Design for This Report
Table 78. Key Data Information from Secondary Sources
Table 79. Key Data Information from Primary Sources
List of Figures
Figure 1. Global ICU-acquired Acute Kidney Treatment Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global ICU-acquired Acute Kidney Treatment Market Share by Type: 2023 VS 2030
Figure 3. Pre-renal Features
Figure 4. Intrinsic-renal Features
Figure 5. Post-renal Features
Figure 6. Global ICU-acquired Acute Kidney Treatment Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global ICU-acquired Acute Kidney Treatment Market Share by Application: 2023 VS 2030
Figure 8. Public Hospital Case Studies
Figure 9. Private Hospital Case Studies
Figure 10. ICU-acquired Acute Kidney Treatment Report Years Considered
Figure 11. Global ICU-acquired Acute Kidney Treatment Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global ICU-acquired Acute Kidney Treatment Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global ICU-acquired Acute Kidney Treatment Market Share by Region: 2023 VS 2030
Figure 14. Global ICU-acquired Acute Kidney Treatment Market Share by Players in 2023
Figure 15. Global Top ICU-acquired Acute Kidney Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in ICU-acquired Acute Kidney Treatment as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by ICU-acquired Acute Kidney Treatment Revenue in 2023
Figure 17. North America ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America ICU-acquired Acute Kidney Treatment Market Share by Country (2019-2030)
Figure 19. United States ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe ICU-acquired Acute Kidney Treatment Market Share by Country (2019-2030)
Figure 23. Germany ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific ICU-acquired Acute Kidney Treatment Market Share by Region (2019-2030)
Figure 31. China ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America ICU-acquired Acute Kidney Treatment Market Share by Country (2019-2030)
Figure 39. Mexico ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa ICU-acquired Acute Kidney Treatment Market Share by Country (2019-2030)
Figure 43. Turkey ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia ICU-acquired Acute Kidney Treatment Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. Quark Pharmaceuticals Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2019-2024)
Figure 46. Fresenius Medical Care Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2019-2024)
Figure 47. B. Braun Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2019-2024)
Figure 48. Baxter international Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2019-2024)
Figure 49. Angion Biomedica Corp Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2019-2024)
Figure 50. Asahi Kasei Medical Revenue Growth Rate in ICU-acquired Acute Kidney Treatment Business (2019-2024)
Figure 51. Bottom-up and Top-down Approaches for This Report
Figure 52. Data Triangulation
Figure 53. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies